Short answer
Intuitive Surgical (ISRG) filed its Q3 2026 10-Q quarterly report on Oct 21, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3.0B (up 21.7% year over year) with net income of $523M.
Q3 2026 key financials · XBRL
- Revenue
- $3.0B
- +21.7% YoY · +5.4% QoQ
- Net income
- $523M
- −25.8% YoY · −36.1% QoQ
- Operating margin
- 19.4%
- Gross margin
- 68.4%
- EPS (diluted)
- $1.50
- −23.1% YoY · −34.5% QoQ
Source: XBRL data from the Intuitive Surgical (ISRG) Q3 2026 10-Q on SEC EDGAR. USD.
Intuitive Surgical Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $3.05B, up 22% YoY from $2.51B, driven by systems revenue growth of 30% to $769M
- Gross margin 68.4% vs 66.4% YoY; product margin 68.9% vs 66.8%, service margin 65.4% vs 63.8%
- Best segment systems revenue $769M, up 30%; worst instruments and accessories still grew 18% to $1.80B
- Cash, equivalents, and investments $6.80B vs $9.03B at December 31, 2025; $2.94B spent on share repurchases
- Outlook: 2027 pricing actions expected to reduce instruments revenue per procedure 3% to 5%; China pricing reductions begin Q4 2026
Risk Factors
- New geopolitical risk: Iran conflict added to Middle East disruptions affecting commodities, supply constraints, and liquidity
- Market risk: tariffs and export controls may increase raw-material and finished-goods costs
- Financial risk: cash and equivalents declined to $2,978.1 million from $3,368.0 million
- Regulatory risk: ASU 2025-05 adoption introduced expected-credit-loss estimation changes, without material financial impact
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Intuitive Surgical quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.